论文部分内容阅读
支气管肺癌是最常见的癌肿,而其中鳞状上皮癌约占50％。文献报道,若不治疗存活期只有4～6个月。治疗鳞状上皮癌是用手术切除。术后病人的5年存活率约20～40％。这与癌的分期有关。过去30年许多有关扩大手术效果的报道说明,单凭外科手术本身,不能影响病人的死亡率或存活期,当手术时,部分病人的命运已决定于癌转移或局部扩散.因此,问题在于术后抗癌化疗能否减少癌的微小转移和局部复发,从而延长病者的存活时间。作者分析了1968～1981年曾经手术的支气管鳞状上皮癌228例。全部病人的手术适应症和手术方式大都相同,经病理检查确诊,并按TNM分期。术后4
Bronchial lung cancer is the most common cancer, and squamous cell carcinoma accounts for about 50%. The literature reports that if no treatment survived for only 4 to 6 months. Treatment of squamous cell carcinoma is surgically removed. The 5-year survival rate of postoperative patients is about 20-40%. This is related to the stage of cancer. In the past 30 years, many reports on the effect of expanding surgery have shown that surgery alone cannot affect the patient’s mortality or survival. When surgery, the fate of some patients has been determined by cancer metastasis or local spread. Therefore, the problem lies in surgery. After anti-cancer chemotherapy can reduce the micrometastasis and local recurrence of cancer, thereby prolonging the patient’s survival time. The authors analyzed 228 cases of bronchial squamous epithelial cancer that had been operated from 1968 to 1981. All patients had the same surgical indications and surgical procedures. They were diagnosed by pathological examination and classified by TNM. Postoperative 4